全文获取类型
收费全文 | 78994篇 |
免费 | 6498篇 |
国内免费 | 2847篇 |
专业分类
耳鼻咽喉 | 829篇 |
儿科学 | 2228篇 |
妇产科学 | 1492篇 |
基础医学 | 8105篇 |
口腔科学 | 1509篇 |
临床医学 | 7413篇 |
内科学 | 8379篇 |
皮肤病学 | 921篇 |
神经病学 | 3560篇 |
特种医学 | 3839篇 |
外国民族医学 | 53篇 |
外科学 | 9416篇 |
综合类 | 13161篇 |
现状与发展 | 19篇 |
预防医学 | 3645篇 |
眼科学 | 887篇 |
药学 | 5726篇 |
51篇 | |
中国医学 | 2438篇 |
肿瘤学 | 14668篇 |
出版年
2024年 | 71篇 |
2023年 | 1172篇 |
2022年 | 2039篇 |
2021年 | 3310篇 |
2020年 | 2873篇 |
2019年 | 2571篇 |
2018年 | 2479篇 |
2017年 | 2593篇 |
2016年 | 2912篇 |
2015年 | 3068篇 |
2014年 | 5061篇 |
2013年 | 5143篇 |
2012年 | 4483篇 |
2011年 | 4997篇 |
2010年 | 4027篇 |
2009年 | 4010篇 |
2008年 | 3987篇 |
2007年 | 4209篇 |
2006年 | 3788篇 |
2005年 | 3299篇 |
2004年 | 2857篇 |
2003年 | 2370篇 |
2002年 | 2200篇 |
2001年 | 1949篇 |
2000年 | 1639篇 |
1999年 | 1472篇 |
1998年 | 1172篇 |
1997年 | 1046篇 |
1996年 | 934篇 |
1995年 | 921篇 |
1994年 | 813篇 |
1993年 | 641篇 |
1992年 | 543篇 |
1991年 | 458篇 |
1990年 | 373篇 |
1989年 | 362篇 |
1988年 | 361篇 |
1987年 | 284篇 |
1986年 | 223篇 |
1985年 | 298篇 |
1984年 | 252篇 |
1983年 | 154篇 |
1982年 | 212篇 |
1981年 | 158篇 |
1980年 | 138篇 |
1979年 | 115篇 |
1978年 | 89篇 |
1977年 | 64篇 |
1976年 | 55篇 |
1974年 | 22篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
肿瘤防控是当今世界性一大难题,目前我国每年新发肿瘤病例即将突破400万。近年来,我国肿瘤总体发病率和死亡率呈现逐年上升趋势,肿瘤的高死亡率和低治愈率已严重威胁我国居民健康,很大程度影响了患者的生存质量,大大降低患者的生活水平,危害患者的身心健康。中医认为,肿瘤发病的病因复杂,病机变化多端,是内外因相互影响、相互作用的结果。若在外邪作用于人体之初,及时辨证施治,防止伏邪入里发生传变,将大大减少肿瘤疾病的发生和发展。因此,外邪理论与肿瘤的发病机制亟待进一步探究。在中国知网(CNKI),Public Medline(PubMed)数据库中以外感、邪气、中医、肿瘤、发病机制等关键词进行检索,本文共纳入67篇中英文文献为参考,对外邪理论与肿瘤发病机制进行全面探讨。强调了外邪在肿瘤发病中的重要作用,以及中医药在早期防治肿瘤中具有显著的优势。外邪如风邪、寒邪、湿邪、火邪、从口鼻皮表而入的邪气等因素,使得肿瘤的发生更具复杂性。中医药可以在肿瘤发展早期进行有效的防护和干预,可大大提高防病抗肿瘤的目的,减少肿瘤的发生、发展、传变,使临床用药更有效、更精准、更具靶向性,不至使肿瘤的治疗错失良机,为临床治疗肿瘤提供更明确的指导方向。 相似文献
42.
目的对近距离治疗计划的剂量参数在Oncentra治疗计划系统与MIM系统间产生的差异进行分析和研究。方法选取本院的43例妇科肿瘤患者近距离治疗计划,按照临床要求所有病例的靶区D90达到处方剂量。评估参数包括:靶区体积和D90,处方剂量总体积,靶区内的处方剂量体积以及危及器官包括:直肠,膀胱,小肠的D0.01cc,D1cc,D2cc。结果计划系统中的靶区体积和处方剂量值均明显小于MIM系统中相应的值(P<0.05),两系统显示出的处方体积相差不大。MIM系统中的靶区D90(676.74±54.82)cGy小于处方剂量,危及器官的受量则正好相反,即计划系统比MIM系统中相应的参数要小,其中直肠和膀胱的D0.01cc,D1cc,D2c,小肠的D0.01cc,D2cc的在两系统显示的值的差异均有统计学意义(P<0.05)。结论不同系统间传输相同的剂量和轮廓文件,DVH参数存在一定的差异,其主要原因是在不同系统对已勾画的各种器官轮廓计算体积存在算法上的不同。基于此,建议近距离计划在CT扫描时,尽量小的层厚可以消除或减少这种差异。 相似文献
43.
Hiroki Teragawa Chikage Oshita Yuichi Orita Kunihiro Hashimoto Hirofumi Nakayama Yuto Yamazaki Hironobu Sasano 《World Journal of Clinical Cases》2021,9(5):1119-1126
BACKGROUNDAdrenal incidentaloma (AI) has been frequently encountered in the clinical setting. It has been shown that primary aldosteronism (PA) or subclinical Cushing’s syndrome (SCS) are the representative causative diseases of AI. However, the coexistence of PA and SCS has been reportedly observed. Recently, we encountered a case of AI, in which PA and SCS coexisted, confirmed by histopathological examinations after a laparoscopic adrenalectomy. We believe that there were some clinical implications in the diagnosis of the present case.CASE SUMMARYA 58-year-old man presented with lower right abdominal pain with a blood pressure of 170/100 mmHg. A subsequent computed tomography scan revealed right ureterolithiasis, which was the cause of right abdominal pain, and right AI measuring 22 mm × 25 mm. After the disappearance of right abdominal pain, subsequent endocrinological examinations were performed. Aldosterone-related evaluations, including adrenal venous sampling, revealed the presence of bilateral PA. In addition, several cortisol-related evaluations showed the presence of SCS on the right adrenal adenoma. A laparoscopic right adrenalectomy was then performed. The histopathological examination of the resected right adrenal revealed the presence of a cortisol-producing adenoma, while CYP11B2 immunoreactivity was absent in this adenoma. However, in the adjacent non-neoplastic adrenal, multiple CYP11B2-positive adrenocortical micronodules were detected, showing the presence of aldosterone-producing adrenocortical micronodules. CONCLUSIONCareful clinical and pathological examination should be performed when a patient harboring AI presents with concomitant SCS and PA. 相似文献
44.
《Clinical neurophysiology》2021,132(7):1416-1432
ObjectiveNeuromonitoring of primary motor regions allows preservation of motor strength and is frequently employed during cranial procedures. Less is known about protection of sensory function and ability to modulate movements, both of which rely on integrity of thalamocortical afferents (TCA) to fronto-parietal regions. We describe our experience with TCA monitoring and their cortical relays during brain tumor surgery.MethodologyTo study its feasibility and usefulness, continuous somatosensory evoked potentials (SSEP) recording via a subdural electrode was attempted in 32 consecutive patients.ResultsMedian and posterior tibial SSEP were successfully monitored in 31 and 17 patients respectively. SSEP improved lesion localization and prevented unnecessary cortical stimulation in 9 and 16 cases respectively. A threshold of ≥30% SSEP amplitude decrease influenced management in 10 patients while a decrement of ≥50 % had a sensitivity of 0.89 and specificity of 1 in detecting worsening of sensory function. Simultaneous motor evoked potentials (MEP) and SSEP monitoring were performed in 10 cases, 9 of which showed short-lived fluctuations of the former.ConclusionDirect cortical SSEP monitoring is feasible, informs management and predicts outcome.SignificanceEarly intervention prevents sensory deficit. Concomitant MEP fluctuations may reflect modulation of motor activity by TCA. 相似文献
45.
《Diagnostic and interventional imaging》2021,102(10):629-639
PurposeTo investigate the reproducibility of diffusion-weighted (DW) MRI and 18F-Fluorodeoxyglucose (18F-FDG)-Positron emission tomography/CT (PET/CT) in monitoring response to neoadjuvant chemotherapy in epithelial ovarian cancer.Materials and methodsTen women (median age, 67 years; range: 41.8–77.3 years) with stage IIIC-IV epithelial ovarian cancers were included in this prospective trial (NCT02792959) between 2014 and 2016. All underwent initial laparoscopic staging, four cycles of carboplatine-paclitaxel-based chemotherapy and interval debulking surgery. PET/CT and DW-MRI were performed at baseline (C0), after one cycle (C1) and before surgery (C4). Two nuclear physicians and two radiologists assessed five anatomic sites for the presence of ≥ 1 lesion. Target lesions in each site were defined and their apparent diffusion coefficient (ADC), maximal standardized uptake value (SUV-max), SUV-mean, SUL-peak, metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were monitored (i.e., 10 patients × 5 sites × 3 time-points). Their relative early and late changes were calculated. Intra/inter-observer reproducibilities of qualitative and quantitative analysis were estimated with Kappa and intra-class correlation coefficients (ICCs).ResultsFor both modalities, inter- and intra-observer agreement percentages were excellent for initial staging but declined later for DW-MRI, leading to lower Kappa values for inter- and intra-observer variability (0.949 and 1 at C0, vs. 0.633 and 0.643 at C4, respectively) while Kappa values remained > 0.8 for PET/CT. Inter- and intra-observer ICCs were > 0.75 for SUV-max, SUL-peak, SUV-mean and their change regardless the time-point. ADC showed lower ICCs (range: 0.013–0.811). ANOVA found significant influences of the evaluation time, the measurement used (ADC, SUV-max, SUV-mean, SUV-max, SUL-peak, MTV or TLG) and their interaction on ICC values (P = 0.0023, P< 0.0001 and P =0.0028, respectively).ConclusionWhile both modalities demonstrated high reproducibility at baseline, only SUV-max, SUL-peak, SUV-mean and their changes maintained high reproducibility during chemotherapy. 相似文献
46.
Kazuko Sakai Takayuki Takahama Mototsugu Shimokawa Koichi Azuma Masayuki Takeda Terufumi Kato Haruko Daga Isamu Okamoto Hiroaki Akamatsu Shunsuke Teraoka Akira Ono Tatsuo Ohira Toshihide Yokoyama Nobuyuki Yamamoto Kazuhiko Nakagawa Kazuto Nishio 《Molecular oncology》2021,15(1):126
The WJOG8815L phase II clinical study involves patients with non‐small cell lung cancer (NSCLC) that harbored the EGFR T790M mutation, which confers resistance to EGFR tyrosine kinase inhibitors (TKIs). The purpose of this study was to assess the predictive value of monitoring EGFR genomic alterations in circulating tumor DNA (ctDNA) from patients with NSCLC that undergo treatment with the third‐generation EGFR‐TKI osimertinib. Plasma samples of 52 patients harboring the EGFR T790M mutation were obtained pretreatment (Pre), on day 1 of treatment cycle 4 (C4) or cycle 9 (C9), and at diagnosis of disease progression or treatment discontinuation (PD/stop). CtDNA was screened for EGFR‐TKI‐sensitizing mutations, the EGFR T790M mutation, and other genomic alterations using the cobas EGFR Mutation Test v2 (cobas), droplet digital PCR (ddPCR), and targeted deep sequencing. Analysis of the sensitizing—and T790M—EGFR mutant fractions (MFs) was used to determine tumor mutational burden. Both MFs were found to decrease during treatment, whereas rebound of the sensitizing EGFR MF was observed at PD/stop, suggesting that osimertinib targeted both T790M mutation‐positive tumors and tumors with sensitizing EGFR mutations. Significant differences in the response rates and progression‐free survival were observed between the sensitizing EGFR MF‐high and sensitizing EGFR MF‐low groups (cutoff: median) at C4. In conclusion, ctDNA monitoring for sensitizing EGFR mutations at C4 is suitable for predicting the treatment outcomes in NSCLC patients receiving osimertinib (Clinical Trial Registration No.: UMIN000022076).
Abbreviations
- CIs
- confidence intervals
- ctDNA
- circulating tumor DNA
- ddPCR
- droplet digital PCR
- EGFR
- epidermal growth factor receptor
- MFs
- mutant fractions
- NGS
- next‐generation sequencing
- NSCLC
- non‐small cell lung cancer
- ORR
- overall response rate
- OS
- overall survival
- PD
- progressive disease
- PFS
- progression‐free survival
- PR
- partial response
- SD
- stable disease
- TKI
- tyrosine kinase inhibitor
47.
孙辉荣 《中国现代普通外科进展》2021,(2):104-106,111
目的:探讨血清p53抗体异常高水平对消化道肿瘤的早期诊断的价值。方法:选取2016年3月至2019年3月来我院检查确诊为消化道肿瘤的患者80例为消化道肿瘤组,选取来我院健康体检的67例健康志愿者为健康对照组。通过酶联免疫吸附实验检测血清中人体抑癌基因p53及其抗体水平;通过RT-qPCR检测血清中细胞凋亡相关基因Bcl-2、Bax和Caspase-3蛋白表达量。采用Pearson相关性分析明确消化道肿瘤p53、p53抗体水平和Bcl-2、Bax、Caspase-3蛋白表达水平的关系。结果:消化道肿瘤组p53水平降低,p53抗体水平异常升高(P<0.05)。与健康对照组相比,消化道肿瘤组Bcl-2表达量增加,Bax和Caspase-3蛋白表达量降低(P<0.05)。消化道肿瘤p53水平与Bcl-2蛋白表达水平呈负相关关系,与Bax、Caspase-3蛋白表达水平均呈正相关关系;p53抗体水平和Bcl-2蛋白表达水平呈正相关关系,与Bax、Caspase-3蛋白表达水平均呈负相关关系(P<0.05)。结论:消化道肿瘤患者血清p53抗体异常高水平,可作为临床辅助诊断消化道肿瘤的可靠指标之一。 相似文献
48.
目的:探讨盆腔腹膜关闭技术在腹腔镜低位直肠癌根治术应用的疗效。方法:回顾性分析2012年1月至2016年5月我院54例腹腔镜低位直肠癌根治术中行盆底腹膜关闭患者和57例未行盆底腹膜关闭患者的临床资料。结果:盆腔腹膜关闭组与盆腔腹膜未关闭组在手术时间、术中出血量、肛门排气时间、术后进食时间以及盆腔引流管拔除时间等方面差异均无统计学意义(P>0.05)。盆腔腹膜关闭组中8例患者发生短期并发症;6例患者发生中期并发症;14例患者发生远期并发症,均为肠梗阻。盆腔腹膜未关闭组中31例患者发生短期并发症,28例患者发生中期并发症,36例患者发生远期并发症。所有患者均治疗好转。Coxs回归模型分析提示,盆腔腹膜是否关闭是腹腔镜低位直肠癌根治术患者术后生存的独立指标。结论:腹腔镜Miles术中行盆底腹膜关闭安全可行,具有临床实用价值。 相似文献
49.
患者男,39岁,面部皮肤肥厚、四肢肢端肥大20年,间断头晕乏力1年。查体:重度贫血貌,睑结膜、口唇及甲床苍白;头面部皮肤肥厚、皱褶、呈回状颅皮;双下肢皮肤肥厚,手指及足趾呈杵状;皮损颜色正常,触之略韧;踝关节肿胀无压痛、活动自如。X线检查提示右腓骨中段髓腔密度增多,腓骨中段及胫骨下段后缘骨皮质增厚。血常规重度正常细胞低色素性贫血,骨髓活检提示骨髓造血衰竭,骨髓纤维化不明显。诊断:原发性骨膜增生厚皮症伴重度贫血。 相似文献
50.
《Respiratory investigation》2021,59(5):695-699
Thymic epithelial tumor is a rare, potentially progressive disease that commonly infiltrates mediastinal structures. In rare cases, it may cause superior vena cava syndrome. Pretreatment histopathological diagnosis is essential to determine the most effective treatment strategy. Percutaneous endovascular biopsy is a rarely reported non-surgical diagnostic option for large vessel tumoral involvement. We report two cases of thymic epithelial tumor with superior vena cava syndrome diagnosed by percutaneous endovascular biopsy. No procedural complications occurred, and subsequent systemic treatment was promptly administered. This procedure may have potential as a useful diagnostic method for patients with mediastinal tumors involving large vessels. 相似文献